| Literature DB >> 7680365 |
A Darveau1, M C Chevrier, S Néron, R Delage, R Lemieux.
Abstract
The use of peripheral B lymphocytes in the successful preparation of human monoclonal antibodies by hybridoma technology is highly dependent on lymphocyte activation procedures. We studied the ability of peripheral human B lymphocytes cultured in vitro and activated through their CD40 antigen (CD40 system) (Banchereau et al., 1991) to form antibody-secreting heterohybridomas after fusion with murine X63Ag8.653 myeloma cells. The frequency of antibody-secreting heterohybridomas formation was greatly increased (15 times) by culture of B cells in the CD40 system. The CD40 system offers many advantages over other procedures of B lymphocyte activation representing a significant technological advance in the preparation of human monoclonal antibodies by standard hybridoma technology.Entities:
Mesh:
Substances:
Year: 1993 PMID: 7680365 DOI: 10.1016/0022-1759(93)90151-v
Source DB: PubMed Journal: J Immunol Methods ISSN: 0022-1759 Impact factor: 2.303